Lipid Management
Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD
K&M Implementation Guidance for NICE TA 694: Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia
K&M ICB Position Statement: Prescribing Inclisiran (Leqvio®) for the treatment of primary hypercholesterolaemia or mixed dyslipidaemia